Equillium, Inc. (EQ) income statement
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.21+0.06 (+5.22%)
Close on Nov 17, 2026Market cap $76.72MP/E –Yield –
Equillium, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -94.0%
Financial strength
- Current ratio
- 23.40
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 2306.9%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.37
- Dividend yield
- –
See a number that looks wrong?